Elite Pharmaceuticals (ELTP) EBIT Margin (2010 - 2026)
Elite Pharmaceuticals' EBIT Margin came in at 23.27% for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 30.69 percentage points from 53.96% a year earlier and down 1.73 percentage points from the prior quarter.
Elite Pharmaceuticals (ELTP) EBIT Margin (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Elite Pharmaceuticals reported EBIT Margin of 24.78%, down 10.72 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it was 32.99%, up 9.67 percentage points from FY2025.
- EBIT Margin has increased in each of the last three fiscal years, with a five-year change of +24.70 percentage points (FY2021 to FY2026).
- Going back by fiscal year, EBIT Margin was 23.32% in FY2025 (+4.27 pp), 19.05% in FY2024 (+8.29 pp), 10.76% in FY2023 (-4.95 pp) and 15.72% in FY2022 (+7.43 pp).
- The five-year range for quarterly EBIT Margin is -4.48% (fiscal Q4 2023) to 53.96% (fiscal Q1 2026).
- Year-over-year, EBIT Margin increased in five of the last eight quarters, with an average year-over-year change of +2.72 percentage points.
- The fastest year-over-year change in EBIT Margin over five years came in fiscal Q4 2022 (a gain of 35.39 percentage points), and the weakest in fiscal Q1 2027 (a drop of 30.69 percentage points).
- Business Quant data shows ELTP's EBIT Margin at 25.00% (Q4 2026), 28.53% (Q3 2026) and 22.61% (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 28.37% |
| 10 | Elite Pharmaceuticals | 258.43 Mn | 140.10 Mn | 13.51 Mn | 23.27% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.27% |
| Mar 31, 2026 | 25.00% |
| Dec 31, 2025 | 28.53% |
| Sep 30, 2025 | 22.61% |
| Jun 30, 2025 | 53.96% |
| Mar 31, 2025 | 34.86% |
| Dec 31, 2024 | 7.64% |
| Sep 30, 2024 | 18.46% |
| Jun 30, 2024 | 20.55% |
| Mar 31, 2024 | 20.77% |
| Dec 31, 2023 | 22.73% |
| Sep 30, 2023 | 13.60% |
| Jun 30, 2023 | 17.84% |
| Mar 31, 2023 | -4.48% |
| Dec 31, 2022 | 21.18% |
| Sep 30, 2022 | 12.59% |
| Jun 30, 2022 | 13.33% |
| Mar 31, 2022 | 11.10% |
| Dec 31, 2021 | 20.40% |
| Sep 30, 2021 | 16.62% |
Elite Pharmaceuticals EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();